Press Release PTI
In the field of cancer research, the tireless efforts of doctors and scientists have led to remarkable breakthroughs in recent years. Innovative work has resulted in the development of new drugs, medicines, and therapies that can either cure or extend the lives of cancer patients. Conventional treatment modalities, such as surgery, chemotherapy, radiation, and immunotherapy, have come a long way in terms of effectiveness and safety, becoming essential tools in the fight against cancer. These advancements have brought hope to millions of patients and their families, and the ongoing efforts of researchers in the field continue to offer promise for a brighter future.
Cervical cancer is the fifth most common cancer among women globally according to World Health Organization (WHO). India accounts for one-fifth (1/5th ) of the global burden of the disease. Every year in India, approximately 1.23 lakh women are diagnosed with cervical cancer and around 67,000 die from the disease. It is the second most common cancer affecting women in India. India has a population of approximately 43 crores women aged 15 years and older who are at risk of developing cervical cancer.
n 2020, the combined age-standardised rate for all cancers, excluding non-melanoma skin cancer, was 190 per 100,000, and men had a greater rate of developing cancer (206.9 per 100,000) than women (178.1 per 100,000). Unfortunately, this number has already been surpassed in the year 2022.
As per the Globocan data 2020, in India, BC accounted for 13.5% (178361) of all cancer cases and 10.6% (90408) of all deaths; hence need measures to either avoid it from developing or reducing recurrence in patients that eventually leads to fatalities. One such measure is Prophylactic Mastectomy, an elective surgery to remove the breasts to reduce the risk of breast cancer in patients carrying a mutation in a specific gene which are hereditary.